Strs Ohio Acquires 3,225 Shares of Encompass Health Co. (NYSE:EHC)

Strs Ohio boosted its stake in shares of Encompass Health Co. (NYSE:EHC) by 2.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 156,477 shares of the company’s stock after buying an additional 3,225 shares during the period. Strs Ohio’s holdings in Encompass Health were worth $10,440,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Sumitomo Mitsui Trust Holdings Inc. boosted its position in Encompass Health by 2.3% during the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,318,784 shares of the company’s stock valued at $87,989,000 after purchasing an additional 29,926 shares in the last quarter. Phocas Financial Corp. boosted its holdings in shares of Encompass Health by 112.4% in the 4th quarter. Phocas Financial Corp. now owns 99,875 shares of the company’s stock valued at $6,664,000 after buying an additional 52,847 shares in the last quarter. Louisiana State Employees Retirement System purchased a new position in shares of Encompass Health in the 4th quarter worth approximately $1,882,000. Allspring Global Investments Holdings LLC raised its stake in shares of Encompass Health by 321.6% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 27,638 shares of the company’s stock worth $1,844,000 after acquiring an additional 21,082 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new stake in Encompass Health in the fourth quarter valued at approximately $20,210,000. Institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Royal Bank of Canada restated an “outperform” rating and set a $83.00 target price on shares of Encompass Health in a research note on Friday, February 9th. Stephens restated an “overweight” rating and set a $85.00 price target on shares of Encompass Health in a research note on Tuesday, January 16th. Mizuho increased their price objective on shares of Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a research report on Friday, February 9th. Truist Financial boosted their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Finally, Barclays boosted their price objective on shares of Encompass Health from $95.00 to $101.00 and gave the company an “overweight” rating in a report on Thursday, March 28th. Eight analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $83.22.

Encompass Health Stock Performance

Shares of EHC stock opened at $79.71 on Thursday. Encompass Health Co. has a 52-week low of $57.55 and a 52-week high of $83.73. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. The stock has a market cap of $7.98 billion, a PE ratio of 22.97, a price-to-earnings-growth ratio of 1.48 and a beta of 0.94. The business has a 50-day simple moving average of $77.15 and a 200-day simple moving average of $70.16.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Wednesday, February 7th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.83 by $0.12. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. The business had revenue of $1.25 billion for the quarter, compared to analysts’ expectations of $1.24 billion. On average, equities analysts expect that Encompass Health Co. will post 3.96 EPS for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.75%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s payout ratio is currently 17.29%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.